Get started
Author

Justin Nicholas

Observed names: J Michael Nicholas, Nicholas, Justin
OpenAlex ID: A5030799896
Progress towards the development of a P. vivax vaccine
2021 · Sai Lata De, Francis B. Ntumngia, et al. · Expert Review of Vaccines · 42
Clinical development, immunogenicity, and interchangeability of follow-on complex drugs
2014 · J Michael Nicholas · Generics and Biosimilars Initiative Journal · 15
PDF
Naturally acquired antibodies against Plasmodium vivax pre-erythrocytic stage vaccine antigens inhibit sporozoite invasion of human hepatocytes in vitro
2024 · Francis Babila Ntumngia, Surendra Kumar Kolli, et al. · Scientific Reports · 11
PDF
Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates
2023 · Justin Nicholas, Sai Lata De, et al. · PLoS neglected tropical diseases · 8
PDF
Longitudinal analysis of antibody responses to Plasmodium vivax sporozoite antigens following natural infection
2024 · Pongsakorn Thawornpan, Justin Nicholas, et al. · PLoS neglected tropical diseases · 5
Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei
2023 · Justin Nicholas, Surendra Kumar Kolli, et al. · Malaria Journal · 4
PDF
Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes
2024 · Pradeep Annamalai Subramani, Phornpimon Tipthara, et al. · Antimicrobial Agents and Chemotherapy · 2
PDF
Transgenic Plasmodium berghei expressing P. vivax pre-erythrocytic antigens SSP3 and SPECT1 to elucidate their efficacy towards vaccine development
2026 · Surendra Kumar Kolli, Pradeep Annamalai Subramani, et al. · PLoS neglected tropical diseases
PDF
Evaluation of immunogenicity and efficacy of a Plasmodium vivax nanoparticle vaccine in mice
2026 · Francis Babila Ntumngia, Surendra Kumar Kolli, et al. · Vaccine
Works count: 11
Citation count: 87
H-index: 5
I10-index: 3
Year
Topic
Type